Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2026-03-08 @ 11:03 PM
Study NCT ID:
NCT01017120
Status:
COMPLETED
Last Update Posted:
2017-05-18
First Post:
2009-11-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne
Sponsor:
Stiefel, a GSK Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-10-01
Start Date Type:
None
Primary Completion Date:
2010-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2009-11-19
First Submit QC Date:
None
Study First Post Date:
2009-11-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-05-31
Results First Submit QC Date:
None
Results First Post Date:
2012-07-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-02-20
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-04-17
Last Update Post Date:
2017-05-18
Last Update Post Date Type:
ACTUAL